Chi | Jotup

Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism

Retrieved on:

Thursday, December 14, 2023

Chi, Trial of the century, Diazoxide, Congenital hyperinsulinism, European Medicines Agency, Patient, Safety, Hypoglycemia, Pharmaceutical industry

REDWOOD CITY, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced the initiation of sunRIZE, a pivotal Phase 3 clinical study of RZ358 in patients with congenital hyperinsulinism (cHI).

Key Points:

REDWOOD CITY, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced the initiation of sunRIZE, a pivotal Phase 3 clinical study of RZ358 in patients with congenital hyperinsulinism (cHI).
Additional sites are being activated on a regular basis over the coming weeks and into the beginning of 2024.
“The start of the Phase 3 study marks a significant milestone in the development of RZ358 and exemplifies the tremendous progress of our Company as a whole.
Following the end of the pivotal treatment period, participants may have the option to enter the open-label extension portion of the study.

Rezolute Reports First Quarter Fiscal 2024 Results

Retrieved on:

Monday, November 13, 2023

Sunrize Band, Safety, European Medicines Agency, Investment, Chi, Patient, Rezolution Pictures, Macular edema, Research, DME, FDA, Pharmacokinetics, Hyperinsulinism, Trial of the century, Neoplasm, Congenital hyperinsulinism, Pharmaceutical industry

REDWOOD CITY, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced its financial results for the first quarter of fiscal 2024 ended September 30, 2023.

Key Points:

REDWOOD CITY, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced its financial results for the first quarter of fiscal 2024 ended September 30, 2023.
“We are on track to commence our Phase 3 study for RZ358 to treat congenital hyperinsulinism prior to year-end and are delighted to have recently obtained PRIME eligibility from the European Medicines Agency for this indication,” said Nevan Charles Elam, Chief Executive Officer and Founder of Rezolute.
“We also anticipate completing enrollment this quarter for our ongoing Phase 2 study of RZ402 for the treatment of diabetic macular edema and plan to provide an update on the study prior to year end.”
Plan to initiate sunRIZE, a pivotal Phase 3 clinical study in patients with cHI, in Europe and other geographies outside the US in the fourth quarter 2023
Continuing the administration of RZ358 in the US with FDA approval under a compassionate use program to treat patients with tumor associated hyperinsulinism, including for a patient with refractory hypoglycemia due to metastatic insulinoma who has remained on RZ358 for nearly a year
Multi-center, randomized, double-masked, placebo-controlled, parallel-arm study ongoing to evaluate the safety, efficacy, and pharmacokinetics of RZ402 administered as a monotherapy over a 12-week treatment period in participants with DME who are naïve to or have received limited anti-VEGF injections
Cash, cash equivalents and investments in marketable debt securities totaled $106.9 million as of September 30, 2023, compared to $118.4 million as of June 30, 2023
Research and development expenses were $12.2 million for the first quarter of fiscal 2024, compared to $7.7 million for the same period in fiscal 2023, with the increase primarily attributable to increased expenditures in clinical trial activities, manufacturing costs and higher personnel-related expenses which included employee compensation and stock-based compensation
General and administrative expenses were $3.7 million for the first quarter of fiscal 2024, compared to $2.5 million for the same period in fiscal 2023, with the increase primarily attributable to higher personnel-related expenses, including employee compensation and stock-based compensation
Net loss was $14.5 million for the first quarter of fiscal 2024, compared to $9.8 million for the same period in fiscal 2023

Indeed, Hillman Grad, and 271 Films Announce Rising Voices Season 4 Filmmakers, Creating More Jobs and Continuing to Increase Diversity in the Entertainment Industry

Retrieved on:

Friday, December 15, 2023

"We're so excited to announce the next class of incredible Rising Voices filmmakers," said Lena Waithe, Hillman Grad Founder and Rishi Rajani, Hillman Grad CEO.

Key Points:

"We're so excited to announce the next class of incredible Rising Voices filmmakers," said Lena Waithe, Hillman Grad Founder and Rishi Rajani, Hillman Grad CEO.
"It's been a tumultuous year in Hollywood, which makes supporting the next generation of underrepresented storytellers even more crucial.
These brilliant artists are the future of our industry and we're proud to be part of their journey."
Rising Voices’ goal is to help change these statistics by creating opportunities for filmmakers from underestimated communities and bring more diversity to the entertainment industry.

ALX Resources Corp. Completes Prospecting Program at McKenzie Lake Uranium Project

Retrieved on:

Tuesday, November 7, 2023

Chi, Uranium, Gunnar Mine, Digestion, OTC, Radioactive decay, News, Project, ALX, Syenite, Weather, CPS, IAEA, Soil, FSE, Růžička, Uranium mining, Typesetting, Rare-earth element, Uranium City

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce the completion of a surface prospecting program in October 2023 at its 100%-owned McKenzie Lake Uranium Project ("McKenzie Lake", or the "Project") located in the southeastern Athabasca Basin area of northern Saskatchewan, Canada.

Key Points:

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce the completion of a surface prospecting program in October 2023 at its 100%-owned McKenzie Lake Uranium Project ("McKenzie Lake", or the "Project") located in the southeastern Athabasca Basin area of northern Saskatchewan, Canada.
Access to the Project in October 2023 was gained by helicopter and supported a three-person geological crew for prospecting.
The geochemical results from sample 149616 returned 844 parts per million ("ppm") uranium (total digestion) with a corresponding uranium assay of 0.101% U3O8.
Most of the uranium deposits in the Beaverlodge (Uranium City) district in northern Saskatchewan are located within or adjacent to 'granitic' (sensu lato) rocks.

Antoine Wade and Rhyan Lamarr's Sneaker Fashion Meets Hip-Hop Series Just for Kicks to Premiere October 19 Exclusively on Crackle

Retrieved on:

Thursday, October 12, 2023

Chicken Soup for the Soul Entertainment (NASDAQ: CSSE) today announced the sneaker lifestyle meets hip-hop culture series Just for Kicks will premiere on October 19 exclusively on the free streaming service Crackle.

Key Points:

Chicken Soup for the Soul Entertainment (NASDAQ: CSSE) today announced the sneaker lifestyle meets hip-hop culture series Just for Kicks will premiere on October 19 exclusively on the free streaming service Crackle.
The series comes from producer/director Rhyan LaMarr and entrepreneur Antoine Wade and features well-known entertainment and NBA stars, including Allen Iverson, Jordan Clarkson, John Salley, Rich the Kid, Bun B., Adam Waheed, Liane V., Barton Fitzpatrick, and many others.
The series features a range of games and challenges like never before that are sure to stump even the most confident shoe aficionados.
“We’re thrilled to launch it next week, exclusively on Crackle.”

DottedSign Empowers CHIMEI’s Paperless Vision, Enhancing Service and Expanding Client Base

Retrieved on:

Tuesday, August 15, 2023

Software as a service, Chi, Printing, API, Organization, GM, Kdan Mobile, Growth, Environment, Online shopping, Renewable energy

CHIMEI has deployed DottedSign to eliminate printing, faxing and overnighting documents to complete transactions.

Key Points:

CHIMEI has deployed DottedSign to eliminate printing, faxing and overnighting documents to complete transactions.
This adoption of DottedSign enables CHIMEI to expedite deal closures, reduce costs and delight partners with a 100% digital experience that's trusted around the globe.
CHIMEI seamlessly integrated the DottedSign API solution into its internal system, resulting in cost savings for training and accelerated operation processes.
"Our vision is to build an environment with a paperless vision, and we believe DottedSign will be the trusted foundation for growth."

Alpha Kappa Alpha Sorority, Inc., Chi Theta Omega Chapter Celebrates 20 Years of Sisterhood and Service in Frederick, Maryland

Retrieved on:

Wednesday, April 19, 2023

Theta, Catoctin, Chi, Education, Politics, Graduate, Health, Economics, MD, Incorporated

FREDERICK, Md., April 19, 2023 /PRNewswire-PRWeb/ -- The Chi Theta Omega Chapter is proud to announce its 20th anniversary in Frederick, Maryland. The chapter has a long-standing history of providing exemplary service to the Frederick community and beyond, with an unwavering commitment to promoting politics, health, economics, and youth education.

Key Points:

FREDERICK, Md., April 19, 2023 /PRNewswire-PRWeb/ -- The Chi Theta Omega Chapter is proud to announce its 20th anniversary in Frederick, Maryland.
The Chi Theta Omega Chapter began as the Clustered Pearls interest group who worked to start a new chapter while engaging in a variety of charitable endeavors in the Frederick region.
"We are honored to celebrate 20 years of service to the Frederick community," said Ms. Sabrina Davis, President of the Chi Theta Omega Chapter.
For more information on the Chi Theta Omega Chapter of Alpha Kappa Alpha Sorority, Incorporated, please visit their website at http://www.chithetaomega.org .

Indeed, Lena Waithe, Hillman Grad, and 271 Films Select 10 Filmmakers for ‘Rising Voices’ Season 3 - BIPOC Filmmakers To Offer Perspective on Future of Work

Retrieved on:

Thursday, January 12, 2023

“We are thrilled to continue this special partnership with Indeed to support diverse filmmakers,” said Lena Waithe, Hillman Grad Founder and Rishi Rajani, Hillman Grad CEO.

Key Points:

“We are thrilled to continue this special partnership with Indeed to support diverse filmmakers,” said Lena Waithe, Hillman Grad Founder and Rishi Rajani, Hillman Grad CEO.
We look forward to working with these amazing filmmakers and providing them with everything they need to succeed.”
The Future of Work theme for Rising Voices for Season 3 comes as we are experiencing a watershed moment in jobs and workplace experiences.
As part of the Rising Voices initiative, filmmakers also receive mentoring and guidance from veteran filmmakers, including: Lena Waithe, Destin Daniel Cretton, Diego Velasco, Anthony Hemingway, Tiff Johnson and Naima Ramos Chapman.
The filmmakers will also be compensated $5,000 for writing their original script and $5,000 for directing.

Global Acrylonitrile Butadiene Styrene Market to 2030: Increasing Infrastructure Programmes Drive Growth - ResearchAndMarkets.com

Retrieved on:

Thursday, January 5, 2023

Increasing production of acrylonitrile butadiene styrene is the key factor behind the growth of this market.

Key Points:

Increasing production of acrylonitrile butadiene styrene is the key factor behind the growth of this market.
As a result, the demand for superior-quality acrylonitrile butadiene styrene is expected to grow in Europe in the coming years.
The market for acrylonitrile butadiene styrene in the region is highly regulated, with stringent regulations applied for the manufacturing of acrylonitrile butadiene styrene by the World Health Organization (WHO).
The production in Japan and Taiwan is scheduled to begin in the first half of 2023
Chapter 3 Acrylonitrile Butadiene Styrene Market Variables, Trends & Scope
3.3 Acrylonitrile Butadiene Styrene Market: Industry Value Chain Analysis

CHIMEI to Launch Ecologue(TM) Bio-ABS Products with ISCC PLUS Approval in 2023

Retrieved on:

Thursday, November 10, 2022

CHIMEI Corporation's factory in Tainan, Taiwan, has obtained International Sustainability and Carbon Certification (ISCC) PLUS for ABS, SAN, MS (SMMA), HBR, and SSBR products.

Key Points:

CHIMEI is preparing to replace some of the fossil feedstock used in its polymer production with bio-based feedstock.
The ISCC PLUS approvals apply to ABS, SAN, MS (SMMA), HBR, and SSBR products, which are produced at CHIMEI's factory in Tainan, Taiwan.
CHIMEI will officially launch ISCC PLUS bio-ABS products, under the Ecologue trademark, in the first half of 2023.
CHIMEI Corporation first received the ISCC PLUS approvals during K 2022, the world-leading trade fair for plastics and rubber.